4-HYDROXYANDROSTENEDIONE ALONE AND IN COMBINATION WITH ZOLADEX IN PREMENOPAUSAL BREAST-CANCER

被引：0
|
作者：
STEIN, RC
DOWSETT, M
HEDLEY, A
COOMBES, RC
机构：
[1] ST GEORGES HOSP,CLIN ONCOL UNIT,LONDON SW17 0RE,ENGLAND
[2] CHELSEA HOSP WOMEN,LONDON SW3 6LT,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1989年 / 59卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
  • [31] INVIVO AND INSITU TUMOR AROMATASE-ACTIVITY IN POST-MENOPAUSAL WOMEN WITH BREAST-CANCER - EFFECT OF 4-HYDROXYANDROSTENEDIONE
    REED, MJ
    GHILCHIK, MW
    LAI, LC
    OWEN, AM
    SINGH, A
    COLDHAM, NG
    SHAIKH, NA
    JAMES, VHT
    BRITISH JOURNAL OF SURGERY, 1988, 75 (12) : 1230 - 1231
  • [32] AROMATIZATION INHIBITION ALONE OR IN COMBINATION WITH GNRH AGONISTS FOR THE TREATMENT OF PREMENOPAUSAL BREAST-CANCER PATIENTS
    DOWSETT, M
    STEIN, RC
    COOMBES, RC
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (1-3): : 155 - 159
  • [33] ZOLADEX IN ADVANCED BREAST-CANCER
    ROBERTSON, JFR
    NICHOLSON, RI
    WALKER, KJ
    BLAMEY, RW
    HORMONE RESEARCH, 1989, 32 : 206 - 208
  • [34] CONCENTRATIONS OF ESTRONE AND 4-HYDROXYANDROSTENEDIONE IN MALIGNANT AND NORMAL BREAST TISSUES
    REED, MJ
    AHERNE, GW
    GHILCHIK, MW
    PATEL, S
    CHAKRABORTY, J
    INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (04) : 562 - 565
  • [35] HORMONAL FOLLOW-UP TREATMENTS WITH ZOLADEX FOR PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CANCER
    VONMINCKWITZ, G
    KAUFMANN, M
    MOHRLE, D
    SCHMID, H
    BASTERT, G
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 258 - 260
  • [36] AROMATASE INHIBITION BY 4-HYDROXYANDROSTENEDIONE IN ADVANCED PROSTATIC-CANCER
    DAVIES, JH
    DOWSETT, M
    COOMBES, RC
    SHEARER, RJ
    BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 492 - 492
  • [37] Isotopic dilution GC-MS measurement of 4-hydroxyandrostenedione in postmenopausal breast cancer
    Danza, G
    Dini, S
    Bartolucci, G
    Lentini, G
    Becorpi, A
    Massi, GB
    Guarna, A
    Serio, M
    ENDOCRINE-RELATED CANCER, 1996, 3 (02) : 137 - 143
  • [38] EFFECT OF 2 4-HYDROXYANDROSTENEDIONE DOSES ON SERUM INSULIN-LIKE GROWTH-FACTOR-I LEVELS IN ADVANCED BREAST-CANCER
    FERRARI, L
    ZILEMBO, N
    BAJETTA, E
    BUZZONI, R
    NOBERASCO, C
    MARTINETTI, A
    CELIO, L
    GALANTE, E
    OREFICE, S
    CERROTTA, AM
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 127 - 132
  • [39] THE USE OF AN LH-RH AGONIST (ICI 118630, ZOLADEX) IN ADVANCED PREMENOPAUSAL BREAST-CANCER
    WILLIAMS, MR
    WALKER, KJ
    TURKES, A
    BLAMEY, RW
    NICHOLSON, RI
    BRITISH JOURNAL OF CANCER, 1986, 53 (05) : 629 - 636
  • [40] EFFECT OF TREATMENT WITH 4-HYDROXYANDROSTENEDIONE ON THE PERIPHERAL CONVERSION OF ANDROSTENEDIONE TO ESTRONE AND INVITRO TUMOR AROMATASE-ACTIVITY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
    REED, MJ
    LAI, LC
    OWEN, AM
    SINGH, A
    COLDHAM, NG
    PUROHIT, A
    GHILCHIK, MW
    SHAIKH, NA
    JAMES, VHT
    CANCER RESEARCH, 1990, 50 (01) : 193 - 196
12345